Radiation protection of stimulated human lymphocytes by nicotinamide.
Nicotinamide (NA) when added to human lymphocytes in vitro together with a mitogen, protected against the inhibition by gamma and UV radiation of stimulated cell growth. When stimulated by phytohemagglutinin (PHA), concanavalin A (Con A) or pokeweed mitogen (PWM) maximum protection has been observed with approximately 1 mM NA (dose reduction factor of 2-3). To obtain protection the cells had to be stimulated immediately after irradiation in the presence of NA. It is suggested that the intracellular level of NAD+ may be rate limiting for excision repair in human lymphocytes irradiated in the G0 phase. This level is presumably increased by exogenously supplied NA, leading to enhanced repair of DNA damage and increased survival.
D002455:Cell Division / Q000187:drug effects / Q000528:radiation effects; D005720:Gamma Rays; D006801:Humans; D008213:Lymphocyte Activation / Q000528:radiation effects; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000528:radiation effects*; D008934:Mitogens; D009536:Niacinamide / Q000494:pharmacology*; D011835:Radiation Protection; D011837:Radiation-Protective Agents; D014466:Ultraviolet Rays
D008934:Mitogens; D011837:Radiation-Protective Agents; D009536:Niacinamide